IGFBP4 Antikörper
(1 reference)-
- Target Alle IGFBP4 Antikörper anzeigen
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGFBP4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of IGFBP4.
- Sequenz
- KGELDCHQLA DSFRE
- Kreuzreaktivität
- Rind (Kuh), Human, Maus
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human IGFBP4.
- Top Product
- Discover our top product IGFBP4 Primärantikörper
-
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) antibody
IGFBP4 Reaktivität: Human, Maus, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibodyIGFBP4 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (Middle Region) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schaf, Ziege, Meerschweinchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 180-229) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schaf, Ziege, Fledermaus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibodyIGFBP4 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal A3 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-254) antibodyIGFBP4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 66-92), (N-Term) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte WB, FACS Wirt: Kaninchen Polyclonal RB20479 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibodyIGFBP4 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 96-124) antibodyIGFBP4 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB20480 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 66-92) antibodyIGFBP4 Reaktivität: Human, Maus WB, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:8000)
Western Blot (1-3 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Biology of insulin-like growth factor binding protein-4 and its role in cancer (review)." in: International journal of oncology, Vol. 28, Issue 6, pp. 1317-25, (2006) (PubMed).
-
: "Biology of insulin-like growth factor binding protein-4 and its role in cancer (review)." in: International journal of oncology, Vol. 28, Issue 6, pp. 1317-25, (2006) (PubMed).
-
- Target
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Andere Bezeichnung
- IGFBP4 (IGFBP4 Produkte)
- Synonyme
- IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper
- Gen-ID
- 3487
- Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-
